Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | 14.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | 14.42% | |||
| Cost of Revenue | -0.48% | 2.31% | |||
| Gross Profit | -0.48% | 17.62% | |||
| SG&A Expenses | -0.48% | 20.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.48% | -151.36% | |||
| Total Operating Expenses | -0.48% | 18.75% | |||
| Operating Income | -0.48% | -4.41% | |||
| Income Before Tax | -0.48% | -33.51% | |||
| Income Tax Expenses | -0.48% | 29.11% | |||
| Earnings from Continuing Operations | -0.48% | -38.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.48% | -38.73% | |||
| EBIT | -0.48% | -4.41% | |||
| EBITDA | -0.48% | -2.61% | |||
| EPS Basic | 0.00% | -37.10% | |||
| Normalized Basic EPS | -1.12% | -9.18% | |||
| EPS Diluted | 0.00% | -38.71% | |||
| Normalized Diluted EPS | 0.00% | -10.20% | |||
| Average Basic Shares Outstanding | 0.00% | -3.07% | |||
| Average Diluted Shares Outstanding | 0.00% | -2.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.00% | -- | |||